KindredBio Results for Equine Gastric Ulcer Pilot Study Treatment

KindredBio announced positive results from its pilot effectiveness study of KIND-014 for the treatment of gastric ulcers in horses.

undefined

Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, announced positive results from its pilot field effectiveness study of KIND-014 for the treatment of gastric ulcers in horses.

This study was a randomized, single-blind, placebo-controlled, dose-ranging study that enrolled 53 horses (40 horses in three KIND-014 groups with different doses and dosing schedules, 13 horses in the placebo group). The objective was to determine the effective dose of KIND-014 for the treatment of gastric ulcers in horses. At Week 3, the gastric ulcer resolution (gastric ulcer score=0) rates in all three KIND-014 groups were statistically significantly higher than the placebo group (p-values < 0.05).

“We are very pleased with the positive results from this study and believe that KIND-014 has the potential to improve the treatment of horses with this important medical need. We look forward to advancing KIND-014 into the next phase of development,” stated Richard Chin, MD, president and chief executive officer of KindredBio.

About Kindred Biosciences

Kindred Biosciences is a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company’s strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes. KindredBio’s first approved drug is Mirataz™ (mirtazapine transdermal ointment) for the management of weight loss in cats.

For more information or to download the corporate presentation, visit http://kindredbio.com/home/investor-information. Stay connected with KindredBio on Facebook.

categories
tags
Trending Articles
Horse Stable
13 Texas Horses Positive for EIA
Happy Horses in Modern Stable
Strangles Confirmed in 3 Michigan Counties
madigan-foal-compression-1-min
Madigan Foal Squeeze Technique
The side view of a rider in jeans, cowboy chaps and checkered shirt on a reining horse slides to a stop in the red clay an arena
Fetlock Radiographs: No Association Between Lameness, Pathology  
Newsletter
Get the best from EquiManagement delivered straight to your inbox once a week! Topics include horse care, disease alerts, and vet practitioner updates.

"*" indicates required fields

Name*
Country*

Additional Offers

Untitled
This field is for validation purposes and should be left unchanged.